申请人:Abbott Laboratories
公开号:US08030504B2
公开(公告)日:2011-10-04
The present application is directed to compounds that are TRPV1 antagonists and have formula (I)
wherein variables Ar1, L1, R1, R2, R3, R4, R5, Y1, Y2, and Y3, are as defined in the description, which are useful for treating disorders caused by or exacerbated by vanilloid receptor activity.
本申请涉及化合物,其为TRPV1拮抗剂,具有公式(I),其中变量Ar1、L1、R1、R2、R3、R4、R5、Y1、Y2和Y3如描述中所定义,其可用于治疗由vanilloid受体活性引起或加重的疾病。